In a large retrospective analysis using measurements of thousands of plasma proteins in primary and secondary event populations, scientists from deCODE genetics a subsidiary of Amgen and collaborators from USA, Denmark and Iceland, reported today in The Journal of the American Medical Association (JAMA) how they employed AI to develop a protein score to predict major atherosclerotic cardiovascular disease events (ASCVD). The study is based on a large data set consisting of over 13,500 Icelanders who had not experienced major ASCVD before plasma sampling and over 6,000 participants in the FOURIER trial who had suffered ASCVD before plasma sampling.

https://www.miragenews.com/single-plasma-sample-protein-score-forecasts-1069842/

#miragenews